Home / Home

Thyroid Cancer Research

Thyroid cancer research covers risk stratification and staging, including aggressive subtypes such as poorly differentiated thyroid carcinoma, as well as surgical and systemic treatment strategies.

Our Thyroid Cancer Analysis

  • November 6, 2026JAMA OncologyIATCCG retrospective cohort with SEER validation (not a registered trial)

    Proposed Thyroid-Specific TNM System Reclassifies 36.6% of Poorly Differentiated Thyroid Cancers, With Level VII Nodes Upgraded to N1c and a Modest Gain in Discrimination

    In an international cohort of 1010 patients with poorly differentiated thyroid carcinoma (PDTC) from 91 centers in 14 countries, the authors propose a PDTC-specific TNM staging system that removes the 55-year age cutoff and classifies level VII (upper mediastinal) nodal disease as a new N1c category. The proposed system reclassified 370 patients (36.6%) relative to TNM-8 (DTC criteria). Level VII lymph node metastasis carried the worst 5-year overall survival, 45.2% (95% CI, 33.4-61.2).